1 Min Read
July 17 (Reuters) - Helix Biopharma Corp
* Helix BioPharma says board has accepted Albert Beraldo’s resignation as director of company and audit committee chair, effective July 14, 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.